Barclays raises The Goldman Sachs Group Inc. [GS]’s rating to Overweight and price target to $362
Barclays took its The Goldman Sachs Group Inc. [NYSE:GS] rating to the equivalent of Overweight from Equal Weight, and the price target to $362, in a research note dated January 4, 2021. That figure represents around a 37.27% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with Morgan […]
Pfizer (PFE), BioNTech (BNTX), AstraZeneca (AZN), Tesla (TSLA), Carrier Global (CARR), General Electric (GE), Goldman Sachs (GS) Among Gainers On Tuesday
Vaccine makers came to be adding to their values on the day. Pfizer Inc (PFE) rose +3.18% to $42.56, BioNTech SE (BNTX) jumped +1.92 percent to $128.11 while AstraZeneca PLC (AZN) added +0.85 percent to $54.72 on Tuesday. While vaccinations begin in the UK with the vaccine from U.S. firm Pfizer and its German partner […]
